Pfizer, Dana-Farber Win Bid For Bristol-Myers Docs In IP Suit
Pfizer Inc. and the Dana-Farber Cancer Institute were allowed access on Friday to what a Boston federal judge described as critical information guarded by Bristol-Myers Squibb Co. and development partner Ono...To view the full article, register now.
Already a subscriber? Click here to view full article